Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis

BACKGROUND: Standard of care treatment for colorectal cancer liver metastasis consists of a cytotoxic chemotherapy in combination with a targeted agent. Clinical trials have guided the use of these combinatory therapies, but it remains unclear what the optimal combinations of cytotoxic chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Min, Zessin, Amelia S., Glover, Wayne, Hsu, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218497/
https://www.ncbi.nlm.nih.gov/pubmed/28060954
http://dx.doi.org/10.1371/journal.pone.0169439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218497/
https://www.ncbi.nlm.nih.gov/pubmed/28060954
http://dx.doi.org/10.1371/journal.pone.0169439

Ejemplares similares